Article
Pharmacodynamics and biodistribution of radiolabeled Platinum-195m (Cisspect) in head and neck squamous cell carcinoma
2023-10-14
Abstract excerpt
<title>Abstract</title> <p>Background Cisplatin- based chemoradiotherapy is a crucial pillar in the treatment of HNSCC. The use of cisplatin comes with a high burden as 35% of patients cannot sustain the planned dose. Unfortunately, there are no clinically applicable biomarkers to predict response. Based on the association of response with the number of DNA adducts and the involved molecular pathway to resolve c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4b8656e8-ea7a-5f6b-8341-b37c60db4c10
- DOI
- 10.21203/rs.3.rs-3407439/v1
